Home

JEREMY MINDICH

CIK 1431207 · last filed 2019-05-23

JEREMY MINDICH is a corporate insider who has filed 21 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing shows the insider sold $12.7M of ITRI on May 23, 2019. Across all open-market trades the lifetime net is −$23.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $647.0M across reported positions. 109 SEC filings were submitted jointly with SCOPIA CAPITAL MANAGEMENT LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$646.97M

Companies

5

Total Filings

21

Lifetime Open-Market Net

-$22.97M

Filer Profile

Reported Address
C/O SCOPIA MANAGEMENT INC
450 SEVENTH AVENUE, 43RD FLOOR
NEW YORK, NY 10123
Related Filers
SCOPIA CAPITAL MANAGEMENT LP — 109 joint filings, latest 2019-05-30
MATTHEW SIROVICH — 109 joint filings, latest 2019-05-30
Scopia Management, Inc. — 85 joint filings, latest 2019-05-30
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ITRI 10%+ Owner 4,005,794 $97.01 $388.60M -$13.75M 7 2019-05-23
Acorda Therapeutics, Inc. (ACOR) Delisted 10%+ Owner 40,551 $0.66 $26.8K -$19.93M 3 2019-01-22
Barzel Industries Inc. (TONSW) Delisted 10%+ Owner 2,559,673 — — $7.40M 3 2009-01-06
SOURCE INTERLINK COMPANIES INC (SORC) Delisted 10%+ Owner 5,282,276 — — -$791.3K 3 2008-07-02
CENT 10%+ Owner 6,194,326 $41.71 $258.37M $4.10M 3 2008-05-09

Recent Filings

21 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-05-23 ITRI Sell (S) −220,344 -$12.66M EDGAR
2019-05-01 ITRI Sell (S) −167,452 -$8.89M EDGAR
2019-03-27 ITRI Sell (S) −194,736 -$9.18M EDGAR
2019-01-22 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −557,432 -$9.30M EDGAR
2018-11-13 ITRI Sell (S) −306,776 -$16.46M EDGAR
2018-10-09 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −615,432 -$10.63M EDGAR
2018-10-03 Acorda Therapeutics, Inc. (ACOR) Delisted Other (J) −563,616 $0 EDGAR
2018-05-29 ITRI Buy (P) +80,000 $4.75M EDGAR
2016-03-11 ITRI Buy (P) +213,068 $8.96M EDGAR
2016-02-24 ITRI Buy (P) +492,056 $19.72M EDGAR
Showing 1–10 of 21
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.